Last reviewed · How we verify

NCT03913065

Head Computed Tomography for Predicting Neurological Outcome After Cardiac Arrest

Completed Last updated 22 March 2024
What this trial tests

trial testing CT in Heart Arrest, Out-Of-Hospital in 400 participants. Completed in 12 March 2023.

Timeline
18 November 2017
Primary endpoint
31 December 2022
12 March 2023

Quick facts

Lead sponsorLund University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment400
Start date18 November 2017
Primary completion31 December 2022
Estimated completion12 March 2023
Sites1 location across Sweden

Drugs / interventions tested

Conditions studied

Sponsor

Lund University

Who can join

18 and older, any sex, with Heart Arrest, Out-Of-Hospital or Computed Tomography. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The European Resuscitation Council (ERC) and the European Society of Intensive Care Medicine (ESICM) joint guidelines for post-resuscitation care recommend a multimodal approach to prognostication of neurological outcome. However, head computed tomography (CT) which is commonly used for predicting long-term neurological outcome after cardiac arrest has not yet been examined prospectively in a clinical trial. The primary purpose of the TTM-2 CT-substudy is to prospectively investigate and compare various methods of diagnosing generalized oedema on CT after cardiac arrest and it´s ability to predict long-term neurological outcome.

Publications & conference data

4 peer-reviewed publications reference this trial (live from Europe PMC):

  1. Standardised and automated assessment of head computed tomography reliably predicts poor functional outcome after cardiac arrest: a prospective multicentre study.
    Lang M, Kenda M, Scheel M, Martola J, et al · · 2024 · cited 15× · PMID 38900283 · DOI 10.1007/s00134-024-07497-2
  2. Prognostic accuracy of head computed tomography for prediction of functional outcome after out-of-hospital cardiac arrest: Rationale and design of the prospective TTM2-CT-substudy.
    Lang M, Leithner C, Scheel M, Kenda M, et al · · 2022 · cited 4× · PMID 36267356 · DOI 10.1016/j.resplu.2022.100316
  3. ESICM LIVES 2023.
    · 2023 · cited 2× · PMID 37874422 · DOI 10.1186/s40635-023-00546-y
  4. Radiological signs of hypoxic-ischaemic encephalopathy on head computed tomography for prediction of poor functional outcome after cardiac arrest - a prospective observational cohort study.
    Lang M, Kenda M, Scheel M, Martola J, et al · · 2025 · cited 1× · PMID 40499676 · DOI 10.1016/j.resuscitation.2025.110675

Verify or expand the search:

Other trials of CT

Trials testing the same drug.

Other recruiting trials for Heart Arrest, Out-Of-Hospital

Currently open trials in the same condition.

Other Lund University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03913065.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing